Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 4
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2267SPP1RNAs and ProteinHumanUpregulated in PT than PN (with 3 fold change) DiagnosticMetastatic HCC v/s Primary HCC p < 0.01Tissue12640447
2590MPV17, EST, GZMB, ITGA6, EST, CENPC1, EST, SPP1, RTF1, CYB5-M, P4HA2, DNMBP, EST, DNAJB4, PRH1, STK23, TCF2, POSTN, SPP1, WIZ, OSMR, EST, ILIA, CD44, EST, MUC6, MTHFD2, ANXA2, PCSK2, RBP1, EST, ITGA6, APRT, PDUM3, TPM2, RNASE3, OSMR, GRK1, SLC14A, FETUB, ANXA2P1, UGT2B15, EST, KIAA0703, AKAP10, AVPRRNAsHumanGenes associated with EHR of HCC PrognosticExtrahepatic recurrence (EHR) v/s Early intrahepatic recurrence (IHR) P< 0.05Tissue17016605
2591ITGA6, SPP1, DNMBP, CD44, POSTNRNAsHumanUpregulated in HCC with EHR than in HCC without EHR. PrognosticHCC with EHR (Extrahepatic recurrence) v/s HCC without EHR. P< 0.05Tissue17016605
2592ITGA6, SPP1RNAsHumanUpregulated in HCC with EHR than HCC without EHR and non-cancerous liver tissue ( also higher expression in HCC without EHR than non-cancerous liver tissue) PrognosticHCC with EHR (Extrahepatic recurrence) v/s HCC without EHR. P< 0.05Tissue17016605

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top